AGIO icon

Agios Pharmaceuticals

214 hedge funds and large institutions have $2.3B invested in Agios Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 80 increasing their positions, 60 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding:

less first-time investments, than exits

New positions opened: | Existing positions closed:

less ownership

Funds ownership:

23% less call options, than puts

Call options by funds: $7.7M | Put options by funds: $9.96M

36% less capital invested

Capital invested by funds: $3.61B → $2.3B (-$1.31B)

80% less funds holding in top 10

Funds holding in top 10: 51 (-4)

Holders
214
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$7.7M
Puts
$9.96M
Net Calls
Net Calls Change

Top Buyers

1 +$23.8M
2 +$16.8M
3 +$14.1M
4
Morgan Stanley
Morgan Stanley
New York
+$13.8M
5
CS
Candriam SCA
Luxembourg
+$13.2M

Top Sellers

1 -$62.6M
2 -$48.1M
3 -$42.6M
4
Alkeon Capital Management
Alkeon Capital Management
New York
-$26.3M
5
AG
Artal Group
Luxembourg
-$20.1M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$277M
2
$193M
3
$168M
4
$145M
5
$134M
6
$120M
7
$109M
8
$77.3M
9
$76.7M
10
$72.3M
11
$63.2M
12
$61.3M
13
$56M
14
$55.4M
15
$43.2M
16
$38.1M
17
$37.9M
18
$37.9M
19
$34.5M
20
$24.7M
21
$19.5M
22
$16.7M
23
$15.5M
24
$15.5M
25
$14.4M